NexoBrid for Thermal Burns

"As of right now, this study is not looking for any more patients. The trial was first posted on May 1st, 2015 and the most recent update was on July 24th, 2022. There are other options available though; 85 trials for thermal burns and 2 for NexoBrid are currently open to enrolling new participants."

"Children aged 0 to 17 that have received thermal burns are eligible for this study. The research team is looking to enroll around 145 total patients."

"The first clinical trial studying NexoBrid was completed in 2015 at University of Utah Health. As of now, a total of 228 have been conducted with 2 live trials. The majority of these studies take place in Seattle, Washington."

"Children who are 17 years old or younger are eligible to participate in this study."

"Harborview Medical Center in Seattle, Washington, Drexel University in Philadelphia, Pennsylvania, and University of Miami in Miami, Florida are 3 of the 15 sites currently running this trial."

"Unfortunately, this study is no longer looking for participants, as is reflected in the clinicaltrials.gov posting. The listing was first made on May 1st, 2015 and edited most recently on July 24th, 2022. There are 87 other trials with open recruitment at this time."

"NexoBrid's safety is based on pre-existing evidence and Phase 3 trial data, which our team has rated as a 3."

"There are 2 active clinical trials being conducted for NexoBrid. The first study began in 2015 and is sponsored by MediWound Ltd. That particular trial reached Phase 3 drug approval stage with the completion of 145 patient cases. As of now, a total of 228 Phase 3 trials have been completed since 2015."

"NexoBrid is an effective medical treatment for deep partial-thickness thermal burns, eschar removal, and deep full-thickness thermal burns."